AlphaRose Therapeutics Inc

CIK 2051498 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for AlphaRose Therapeutics Inc.

Recent SEC filings

FiledFormAccession number
Oct 6, 2025C-U0002051498-25-000002
Aug 27, 2025C/A0001665160-25-001394
Aug 14, 2025C/A0001665160-25-001371
Jun 17, 2025C/A0001665160-25-001223
Jun 17, 2025C/A0001665160-25-001223
Apr 29, 2025C-AR0001665160-25-000789
Mar 18, 2025C/A0001665160-25-000427
Jan 29, 2025C0001665160-25-000154